The use of individual or group of biochemical markers have advanced some of the understanding on the mechanisms leading to spontaneous preterm birth. Preterm birth is a delivery that occurs at less than 37 completed weeks of gestation and it is associated with prenatal morbidity and mortality. In a point
News
News
WEQAS are pleased to release the latest issue of our Newsletter. We would like to inform you of what is happening in the quality arena, our organisation news, accreditation and service updates. In this issue, please find: * POCT Creatinine and the merits of accreditation. * WEQAS User Group Meeting
Weqas- IQC Use Weqas IQC for accurate, independent, unbiased daily monitoring. Weqas has developed a wealth of knowledge and experience in the production and distribution of high quality clinical material, representing surrogate patient samples. We are pleased to announce the launch of our Third Party Control (IQC) to assist
We are pleased to announce the launch of our Weqas Drugs of Abuse scheme (DOA), join today to take full advantage of the benefits of joining a Weqas scheme at no extra cost. This Pilot scheme will remain free of charge until April 2016, an early bird opportunity too good
Ethylene Glycol and Methanol are now available as part of our ED Toxicology scheme; these analytes have been added In response to the ‘NHS Services, Seven Day Working’ from NHS England. The Association for Clinical Biochemistry and Laboratory Medicine published guidance on the clinical biochemistry tests that may be required
3rd EFLM-BD European Conference on Pre-analytical phase, Porto, Portugal, March 20-21st 2015. Pre-analytical errors present great challenges to the Laboratory; they are often outside the control of the Laboratory and are frequently due to human error at the sampling and transport stage. Weqas will be represented at this conference by
